Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Cognirox Injection

Prescription Icon
Prescription Required

Marketer

Jagsam Pharma

Salt Composition

Cerebroprotein Hydrolysate (2100mg)

Overview Cognirox Injection

CerebroBoost injection is a prescription medication indicated for stroke, traumatic brain injury, and Alzheimer's disease management. Its administration, potentially alone or alongside other therapies, is determined by the specific condition. CerebroBoost is administered solely under the direct supervision of a qualified healthcare provider. For consistent blood levels, consistent daily timing is recommended. Missed doses should be taken immediately upon recollection; never skip doses, and complete the prescribed course even with symptom improvement. Discontinuation requires prior consultation with your physician. Pre-existing epilepsy or severe renal impairment contraindicate its use. While generally well-tolerated, potential side effects include injection site discomfort (pain or erythema), nausea, headache, and vertigo. Dizziness and somnolence may also occur; avoid driving or activities requiring alertness until the medication's effects are understood.

Primary Ingredients of Cognirox Injection

No text provided to rephrase.

Uses of Cognirox Injection

Dementia from Alzheimer's|Cerebrovascular accident|Traumatic brain injury

Major Benefits of Cognirox Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Cognirox Injection:

  • Headache
  • Nausea
  • Vertigo
  • Sweating
  • Fever
  • Anxiety
  • Hallucination
  • Confusion
  • Agitation
  • Flu-like symptoms

How to use Cognirox Injection:

This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.

How Cognirox Injection works:

NeuroMend Injection promotes neural regeneration. Its mechanism of action involves repairing brain nerve cells and enhancing their viability.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cognirox Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Cognirox Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Cognirox Injection use while breastfeeding is lacking. Seek your physician's advice.

DrivingDrivingUNSAFE

Administering Cognirox Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Cognirox Injection due to potential safety concerns. A physician's consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Cognirox Injection's use in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Cognirox Injection :

Should you forget a Cognirox Injection, administer it immediately. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Cognirox Injection

LabelValue
Chemical Classification Modified amino acids
Developing Habits No.
Type of Therapy Neuroscience, Central Nervous System

FAQs on Cognirox Injection

Derived from pig brain tissue, cerebroprotein hydrolysate is an extract that safeguards nerve cells and enhances cognitive function by acting on the central nervous system.
Administered by a healthcare professional as a 15-minute injection, the timeframe may adjust based on dosage and administration method.
Administered either intramuscularly or intravenously.
Symptom improvement may be noticeable within two weeks, though this varies depending on individual condition, treatment response, and prescribed dosage.
Cognirox Injection should be administered daily for 10 to 20 days, as directed. Treatment duration may vary depending on individual patient factors, such as age and condition.
Individuals with severe kidney disease should not receive this medication, despite a lack of evidence linking it to worsened kidney function.
Hospital administration of Cognirox Injection by qualified professionals minimizes the risk of overdose. Nevertheless, doctors will provide immediate emergency care should an overdose be suspected.
Cognirox Injection
1,108
MRP 1,350
17% off